Current:Home > reviewsSouthwest faces investigation over holiday travel disaster as it posts a $220M loss -CapitalCourse
Southwest faces investigation over holiday travel disaster as it posts a $220M loss
View
Date:2025-04-17 07:07:00
The U.S. Department of Transportation is investigating the Southwest Airlines holiday travel debacle, which left thousands of travelers stranded for days. The investigation comes as the airline reported a $220 million loss last quarter and further losses in the first quarter.
Southwest canceled more than 16,700 flights over several days in late December. While a massive winter storm caused the initial cancellations, the company's outdated software systems turned what should have been a normal problem into a snowballing disaster that lasted for days after other airlines had resumed their usual operations.
The department's investigation will look into whether Southwest made unrealistic flight schedules, "which under federal law is considered an unfair and deceptive practice," according to a department spokesperson.
"DOT has made clear to Southwest that it must provide timely refunds and reimbursements and will hold Southwest accountable if it fails to do so," the department spokesperson said.
The flight cancellations cost the company about $800 million, according to Bob Jordan, the airline's president and chief executive officer.
About half of those losses come directly from the flight cancellations. The rest largely come from compensating customers who bought tickets on other airlines and dispensing extra frequent flier points, which are worth about $300 per passenger.
Passengers and employees alike were frustrated by the company's lack of communication during and immediately after the cancellations.
In the report announcing the losses, Jordan apologized to customers and employees, saying the company has "swiftly taken steps to bolster our operational resilience and are undergoing a detailed review of the December events."
Fewer people are booking with Southwest due to the December 2022 disaster. The company is expecting to lose over $300 million in revenue in the first quarter, though it reports that booking trends are improving.
veryGood! (5627)
Related
- Federal appeals court upholds $14.25 million fine against Exxon for pollution in Texas
- Rihanna and A$AP Rocky Celebrate Son RZA's First Birthday With Adorable Family Photos
- Damar Hamlin is in 'good spirits' and recovering at a Buffalo hospital, team says
- Damar Hamlin is in 'good spirits' and recovering at a Buffalo hospital, team says
- A Mississippi company is sentenced for mislabeling cheap seafood as premium local fish
- 24-Hour Flash Deal: Save 42% On This Attachment That Turns Your KitchenAid Mixer Into an Ice Cream Maker
- Tulsi Gabbard on Climate Change: Where the Candidate Stands
- Chef Sylvain Delpique Shares What’s in His Kitchen, Including a $5 Must-Have
- Meet first time Grammy nominee Charley Crockett
- As Diesel Spill Spreads, So Do Fears About Canada’s Slow Response
Ranking
- Meta releases AI model to enhance Metaverse experience
- Qantas on Brink of £200m Biojet Fuel Joint Venture
- Qantas on Brink of £200m Biojet Fuel Joint Venture
- FEMA Flood Maps Ignore Climate Change, and Homeowners Are Paying the Price
- Meta donates $1 million to Trump’s inauguration fund
- West Virginia Said to Be Considering a Geothermal Energy Future
- Time is fleeting. Here's how to stay on track with New Year's goals
- 5 low-key ways to get your new year off to a healthy start
Recommendation
Biden administration makes final diplomatic push for stability across a turbulent Mideast
Army Corps Halts Dakota Access Pipeline, Pending Review
27 Stars Share Their Go-To Sunscreen: Sydney Sweeney, Olivia Culpo, Garcelle Beauvais, and More
You'll Burn for Jonathan Bailey in This First Look at Him on the Wicked Set With Ariana Grande
Woman dies after Singapore family of 3 gets into accident in Taiwan
Climate Change Puts U.S. Economy and Lives at Risk, and Costs Are Rising, Federal Agencies Warn
The FDA approves an Alzheimer's drug that appears to modestly slow the disease
Is it time for a reality check on rapid COVID tests?